Results 181 to 190 of about 603,166 (389)
A call to action for adverse drug event (ADE) detection and prevention
Frontiers in Digital HealthInjury from medication use, known as an adverse drug event (ADE) accounts for millions of emergency department visits globally and thousands of hospitalizations annually within the United States.
John McCue +5 more
doaj +1 more source
Why are the Children Dying?: Mixed-Race Children in Chang-rae Lee’s First Five Novels [PDF]
, 2017 The mixed-race children in each of Lee’s first five novels constitute an overarching set of symbols, reflecting, at first, society’s intolerance of miscegenation and its resulting mixed offspring, as demonstrated in the dysfunctional behaviors of the ...
Martin, Holly E
core +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun +4 more
wiley +1 more source
Instantaneous Orthostatic Hypotension in Children and Adolescents: A New Entity of Orthostatic Intolerance [PDF]
, 1999 Hidetaka Tanaka +3 more
openalex +1 more source
The Role of Intolerance of Uncertainty and Working Alliance in the Outcome of Cognitive Behavioral Therapy for Generalized Anxiety Disorder Delivered by Videoconference: Mediation Analysis [PDF]
, 2021 Gabrielle Marcotte-Beaumier +6 more
openalex +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aims To determine breastmilk concentrations of doravirine via PBPK modelling in combination with a clinical lactation study. As women living with HIV are not able to cease antiretroviral therapy during lactation, it is necessary to establish drug transfer into breastmilk to determine exposure of the infant to antiretroviral drugs and potential risk of ...
Lena van der Wekken‐Pas +3 more
wiley +1 more source
Hepatology, EarlyView., 2022 Phase 1b study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis. Abstract Background and Aims We evaluated the efficacy and safety of the antiangiogenic tyrosine kinase inhibitor anlotinib plus TQB2450, a programmed death‐ligand 1 inhibitor in pretreated advanced biliary tract cancers (BTCs ...
Jun Zhou +13 more
wiley +1 more source
Pulsed Azithromycin for the Treatment of Dacomitinib Induced Skin Toxicity in Patient with Tetracycline Intolerance – A Case Report [PDF]
Wei Ho +4 more
openalex +1 more source
Distress Intolerance and Smoking Topography in the Context of a Biological Challenge [PDF]
, 2018 Samantha G. Farris +4 more
openalex +1 more source